2012 Olympic Games

  • Email
  • Help

This page provides information on the European Medicines Agency's activities during the 2012 Olympic and Paralympic Games, which will be taking place close to the Agency's offices in London.

Meeting venues

The Agency will be working as usual during the games period, but travel to and from London is likely to be difficult in late June and in July.

Some of the Agency's meetings during this period are being cancelled, held virtually or held in the offices of medicines regulatory agencies elsewhere in the European Economic Area.

MeetingDateLocation
Co-ordination Group for Mutual Recognition and Decentralised Procedures – Human18-20/06/2012Norwegian Medicines Authority, Norway
Scientific Advice Working Party25-27/06/2012Medicines Authority, Malta
(Invented) Name Review Group26/06/2012Cancelled
Paediatric Committee04-06/07/2012Paul-Ehrlich Institut, Germany
Committee on Herbal Medicinal Products (plenary and working parties)09-12/07/2012Cancelled
Committee for Orphan Medicinal Products10-12/07/2012Medical Products Agency, Sweden
Committee for Medicinal Products for Veterinary Use10-12/07/2012Medicines Evaluation Board, the Netherlands
Scientific Advice Working Party - Veterinary10/07/2012Medicines Evaluation Board, the Netherlands
Committee for Advanced Therapies11-13/07/2012Held virtually
Co-ordination Group for Mutual Recognition and Decentralised Procedures – Veterinary12-13/07/2012Medicines Evaluation Board, the Netherlands
Committee for Medicinal Products for Human Use16-19/07/2012Federal Institute for Drugs and Medical Devices, Germany
Pharmacovigilance Working Party16-18/07/2012Federal Institute for Drugs and Medical Devices, Germany
Co-ordination Group for Mutual Recognition and Decentralised Procedures – Human16-18/07/2012Medicines Evaluation Board, the Netherlands
Pharmacovigilance Risk Assessment Committee19-20/07/2012European Commission, Belgium

 

Attending oral explanations

Companies invited to attend for oral explanations at meetings held off-site will need to liaise with the Agency for detailed information on meeting venues.

The regulatory authorities in Member States have strict policies for allowing access to representatives of the pharmaceutical industry. Companies will need to supply lists of attendees in advance to the authority hosting the meeting, with only those representatives included on the list of attendees being permitted to enter the premises.

Company representatives will need to be accompanied at all times.

Electronic submission of applications

The Agency encourages applicant to use the eSubmission Gateway when submitting dossiers during the Olympic period. Companies can use the eSubmission Gateway to send centralised procedure submissions to the Agency in electronic common technical document (eCTD) format instead of sending CDs or DVDs via courier mail.

How useful is this page?

Average rating:

 Based on 12 ratings

Add your rating:

See all ratings
3 ratings
0 ratings
0 ratings
6 ratings
3 ratings

Related information

Contact point:

info@ema.europa.eu